A new Wayne State University study found 80.4 percent of incoming medical students want cannabis added to the curriculum, yet two thirds say they feel unprepared to counsel patients about it. For decades the doctor’s office was the last place to bring up marijuana. That is changing fast, and federal rescheduling is accelerating it. For operators, this is a demand signal hiding in a medical journal: the medical channel is about to get more professional, and the brands that educate will win it.
What the Wayne State Study Found
Researchers surveyed 250 incoming medical students before classes started. The enthusiasm is real: 80.4 percent support adding medical cannabis to the curriculum, 73.6 percent want it in residency training, and 76 percent agree cannabis helps patients with chronic, debilitating conditions. The knowledge is not: students answered barely half the questions on medical indications correctly and even fewer on adverse effects and THC versus CBD differences. About 34.4 percent said they knew someone who used medical cannabis, and that group scored higher, which means personal experience is doing the job formal education has not. Fewer than 10 percent of medical school curricula include any cannabis content at all.
Why This Matters for Medical Cannabis Operators
Here is the operator read. A generation of physicians is entering practice with open minds and empty toolboxes. When they look for reliable product information, dosing guidance, and patient education materials, someone will provide it. That someone should be professional operators, not random internet forums. The study also lands right as federal rescheduling formally recognizes marijuana’s accepted medical use for the first time, with 40 states running medical programs. The stigma barrier is falling at the exact moment the knowledge barrier is exposed. That gap is a market opportunity.
I have seen this movie before on the product side: RSO went from a plastic syringe to a precisely dosed tablet because medical credibility demands professional products. Education is the next step in that same evolution. And for the policy backdrop, Tennessee’s 99 page medical cannabis proposal shows how seriously states are taking program design.
How to Position Your Brand for the Shift
Three moves. First, build real education assets: dosing guides, condition specific explainers, and clinician friendly one pagers that a doctor could actually hand to a patient. Second, invest in product consistency and clear labeling, because a physician will never recommend a product with mystery dosing. Third, start the conversation with the medical community now, while the curriculum is still being written. The brands that help write the education will own the trust that comes with it. The researchers called for standardized, evidence based medical cannabis education across medical training. Operators who show up with science instead of slogans will be the ones doctors remember.
Frequently Asked Questions
- What did the Wayne State study find? Incoming medical students strongly support cannabis education, 80.4 percent want it in the curriculum, but they score poorly on knowledge tests and two thirds feel unprepared to counsel patients.
- Why do medical students feel unprepared? Fewer than 10 percent of medical school curricula include cannabis content, so students rely on personal experience instead of formal, evidence based education.
- How does federal rescheduling factor in? In April 2026 the DEA moved state licensed medical marijuana to Schedule III, the first federal recognition of accepted medical use. That opens the door to more research and better information for doctors.
- What does this mean for cannabis operators? A generation of open minded physicians will soon need reliable product and dosing information. Operators who build real education assets can earn trust in the medical channel.
- How can brands work with the medical community? Create clinician friendly education materials, keep products consistent and clearly labeled, and engage the medical community while curricula are still being written.